138 related articles for article (PubMed ID: 38259164)
21. Statistical harmonization can improve the development of a multicenter CT-based radiomic model predictive of nonresponse to induction chemotherapy in laryngeal cancers.
Masson I; Da-Ano R; Lucia F; Doré M; Castelli J; Goislard de Monsabert C; Ramée JF; Sellami S; Visvikis D; Hatt M; Schick U
Med Phys; 2021 Jul; 48(7):4099-4109. PubMed ID: 34008178
[TBL] [Abstract][Full Text] [Related]
22. Induction chemotherapy of modified docetaxel, cisplatin, 5-fluorouracil for laryngeal preservation in locally advanced hypopharyngeal squamous cell carcinoma.
Li R; Ye L; Zhu Y; Ding H; Wang S; Ying H; Wu C; Zhou L; Wang X; Tian S
Head Neck; 2022 Sep; 44(9):2018-2029. PubMed ID: 35915867
[TBL] [Abstract][Full Text] [Related]
23. Larynx preservation.
Lefebvre JL
Curr Opin Oncol; 2012 May; 24(3):218-22. PubMed ID: 22450148
[TBL] [Abstract][Full Text] [Related]
24. Larynx preservation using induction chemotherapy plus radiation therapy as an alternative to laryngectomy in advanced head and neck cancer. A long-term follow-up report.
Karp DD; Vaughan CW; Carter R; Willett B; Heeren T; Calarese P; Zeitels S; Strong MS; Hong WK
Am J Clin Oncol; 1991 Aug; 14(4):273-9. PubMed ID: 1713738
[TBL] [Abstract][Full Text] [Related]
25. CT-based radiomics signature analysis for evaluation of response to induction chemotherapy and progression-free survival in locally advanced hypopharyngeal carcinoma.
Liu X; Long M; Sun C; Yang Y; Lin P; Shen Z; Xia S; Shen W
Eur Radiol; 2022 Nov; 32(11):7755-7766. PubMed ID: 35608663
[TBL] [Abstract][Full Text] [Related]
26. Tumor angiogenesis as a predictive marker for organ preservation in patients with advanced laryngeal carcinoma.
Teknos TN; Cox C; Barrios MA; Chepeha DB; Bradford CR; Fisher SG; Wolf GT
Laryngoscope; 2002 May; 112(5):844-51. PubMed ID: 12150616
[TBL] [Abstract][Full Text] [Related]
27. Organ Preservation for Advanced Larynx Cancer: Issues and Outcomes.
Forastiere AA; Weber RS; Trotti A
J Clin Oncol; 2015 Oct; 33(29):3262-8. PubMed ID: 26351339
[TBL] [Abstract][Full Text] [Related]
28. Combined modality therapy for laryngeal and hypopharyngeal cancer.
Sannazzari GL; Gabriele P; Redda MG; Verna R
Rays; 1997; 22(3):360-71. PubMed ID: 9446940
[TBL] [Abstract][Full Text] [Related]
29. Phase II organ-preservation trial: Concurrent cisplatin and radiotherapy for advanced laryngeal cancer after response to docetaxel, cisplatin, and 5-fluorouracil-based induction chemotherapy.
Popovtzer A; Burnstein H; Stemmer S; Limon D; Hili O; Bachar G; Sopov V; Feinmesser R; Groshar D; Shvero J
Head Neck; 2017 Feb; 39(2):227-233. PubMed ID: 27556178
[TBL] [Abstract][Full Text] [Related]
30. [Organ preservation in advanced laryngeal/hypopharyngeal carcinoma: lessons from the DeLOS-II trial].
Dietz A; Wichmann G; Kuhnt T; Wiegand S
HNO; 2020 Sep; 68(9):648-656. PubMed ID: 32468135
[TBL] [Abstract][Full Text] [Related]
31. Expression of Bcl-2 family proteins in advanced laryngeal squamous cell carcinoma: correlation with response to chemotherapy and organ preservation.
Trask DK; Wolf GT; Bradford CR; Fisher SG; Devaney K; Johnson M; Singleton T; Wicha M
Laryngoscope; 2002 Apr; 112(4):638-44. PubMed ID: 12150516
[TBL] [Abstract][Full Text] [Related]
32. Dual-energy computed tomography for prediction of loco-regional recurrence after radiotherapy in larynx and hypopharynx squamous cell carcinoma.
Bahig H; Lapointe A; Bedwani S; de Guise J; Lambert L; Filion E; Roberge D; Létourneau-Guillon L; Blais D; Ng SP; Nguyen-Tan PF
Eur J Radiol; 2019 Jan; 110():1-6. PubMed ID: 30599844
[TBL] [Abstract][Full Text] [Related]
33. Machine learning-based FDG PET-CT radiomics for outcome prediction in larynx and hypopharynx squamous cell carcinoma.
Zhong J; Frood R; Brown P; Nelstrop H; Prestwich R; McDermott G; Currie S; Vaidyanathan S; Scarsbrook AF
Clin Radiol; 2021 Jan; 76(1):78.e9-78.e17. PubMed ID: 33036778
[TBL] [Abstract][Full Text] [Related]
34. Expression of p53 and Bcl-xL as predictive markers for larynx preservation in advanced laryngeal cancer.
Kumar B; Cordell KG; D'Silva N; Prince ME; Adams ME; Fisher SG; Wolf GT; Carey TE; Bradford CR
Arch Otolaryngol Head Neck Surg; 2008 Apr; 134(4):363-9. PubMed ID: 18427001
[TBL] [Abstract][Full Text] [Related]
35. CT radiomics nomogram predicts pathological response after induced chemotherapy and overall survival in patients with advanced laryngeal cancer: A single-center retrospective study.
Kang C; Sun P; Yang R; Zhang C; Ning W; Liu H
Front Oncol; 2023; 13():1094768. PubMed ID: 37064100
[TBL] [Abstract][Full Text] [Related]
36. Clinical Predictors of Laryngeal Preservation Rate in Stage III-IV Laryngeal Cancer and Hypopharyngeal Cancer Patients Treated with Organ Preservation.
Tangsriwong K; Jitreetat T
Asian Pac J Cancer Prev; 2019 Jul; 20(7):2051-2057. PubMed ID: 31350965
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic Assessment (Imaging) and Staging of Laryngeal Cancer.
Itamura K; Hsue VB; Barbu AM; Chen MM
Otolaryngol Clin North Am; 2023 Apr; 56(2):215-231. PubMed ID: 37030936
[TBL] [Abstract][Full Text] [Related]
38. MRI-based radiomics nomogram may predict the response to induction chemotherapy and survival in locally advanced nasopharyngeal carcinoma.
Zhao L; Gong J; Xi Y; Xu M; Li C; Kang X; Yin Y; Qin W; Yin H; Shi M
Eur Radiol; 2020 Jan; 30(1):537-546. PubMed ID: 31372781
[TBL] [Abstract][Full Text] [Related]
39. Otorhinolaryngologists' personal treatment preferences (total laryngectomy or laryngeal preservation) when faced with advanced stage laryngeal cancer.
Laccourreye O; Malinvaud D; Ménard M; Consoli S; Giraud P; Bonfils P
Eur Ann Otorhinolaryngol Head Neck Dis; 2014 Dec; 131(6):339-343. PubMed ID: 24993784
[TBL] [Abstract][Full Text] [Related]
40. Surgical approach to organ preservation in the treatment of cancer of the larynx.
Weinstein GS
Oncology (Williston Park); 2001 Jun; 15(6):785-96; discussion 798-803. PubMed ID: 11430209
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
